jueves, 25 de mayo de 2017

Your monthly update of news from BioMed Central

BioMed Central – The Open Access Publisher
BioMed Central Update
A roundup of recent events
On 26th April, BioMed Central and SpringerOpen signed the San Francisco Declaration on Research Assessment(DORA).

By signing DORA, BioMed Central and SpringerOpen pledge to “greatly reduce emphasis on the journal Impact Factor as a promotional tool by presenting the metric in the context of a variety of journal-based metrics.” Rachel Burley, Publishing Director at BioMed Central, explains this further in her blog.

A new report issued by BioMed Central and Digital Science concludes that in order to affect real, industry-wide improvements to the peer review process, publishers, researchers, funders and institutions need to be willing to experiment with different models, encourage more diversity in the reviewer pool, utilize Artificial Intelligence (AI) and support training and mentoring for peer reviewers.
What might peer review look like in 2030?’is based on the sessions from the SpotOn London conference, it examines how peer review can be improved for future generations of academics and offers key recommendations to the academic community. The report can be found on Figshare here. Parts of it have also been posted on the BioMed Central blog network here. For more information about SpotOn please visit the website.

Springer Nature is introducing a new service intended to help researchers more easily share data and other files generated during their research.
These services build on our Research Data Support helpdesk and will help authors comply with funder policies, prepare their data for deposition in a repository and enhance their peer-reviewed publications.
Springer Nature is the first publisher to pilot this new data submission portal and has worked closely with Figshare to build a customised service. Iain Hrynaszkiewicz, Head of Data Publishing at Springer Nature, provides more information in his blog.

Springer Nature has announced two new initiatives in support of ORCID, which gives researchers a unique, personal, persistent identifier (an iD) that distinguishes them from every other researcher and ensures they receive proper credit for their work.
The first initiative is a trial that will mandate ORCID iDs for corresponding authors publishing in 46 journals from across the whole of Springer Nature. The second initiative will see Springer become the first publisher to include ORCID iDs in proceedings papers. Further information can be found here.
Journals from BioMed Central trialling the ORCID mandate are: BMC Evolutionary Biology; BMC Genetics; BMC Microbiology; BMC Neuroscience; BMC Veterinary Research; BMC Anesthesiology; BMC Cardiovascular Disorders; BMC Medical Genetics; BMC Medical Informatics and Decision Making; BMC Women’s Health.

Registration of clinical trials and other studies is the first step towards transparency and the future dissemination of research outcomes.
BMC journals require registration before publication of the protocol and/or the results.
The ISRCTN registry, administered by BioMed Central and recognised by the WHO and ICMJE, accepts all study designs involving human subjects, whether interventional or observational, proposed, ongoing or completed. Register your study here.

Understanding research and publication ethics is vital for researchers, and being fully aware of the requirements is important to prevent difficulties arising. The next in our series of webinars with HSG will look at this topic and include how journal editors address different issues and discussion of case studies. To join, sign up here.

News from our journals
BMC Biology has become the first dedicated biology journal to accept Registered Reports. This innovative approach to publishing allows authors to submit their rationale and methods for peer-review before any experiments are conducted. Articles that pass peer-review will be accepted in principle meaning that, as long as the study is completed in accordance with the pre-registered methodology, the article will be published following a second round of peer-review. Further information can be found on the journal website.

This month Cardiovascular Diabetology is proud to be celebrating its 15th anniversary. Based on the idea of professors Alexander Tenenbaum and Enrique Fisman of creating a scientific journal specifically dedicated to exploring the intersection of diabetes and heart disease, BioMed Central founded the journal in 2002. We have gathered some of the most noteworthy articles from the journal in a special collection, along with a timeline of major milestones and more.

BMC Rheumatology, the newest journal in the BMC series, is now open for submissions. It is being launched to provide the rheumatology community with an open access avenue to disseminate research findings with the ultimate aim of improving patient care.

As a member of the BMC series, the ethos of BMC Rheumatology will be open and inclusive, and submissions will be rigorously peer reviewed to assess scientific validity. As an open access peer-reviewed journal, published articles will be freely available to all readers whatever their location. Read journal editor James Mockridge’s blog for more information about this exciting new development.

Other news of interest
We are living in times of unprecedented scientific, technical and medical advancement, yet we are faced with critical global issues that threaten human welfare and our environment.

We’ve asked the Editors-in-Chief of Springer Nature journals across disciplines to select the scientific findings published in 2016 that they believe could have the greatest impact on society’s most pressing problems. Read over 180 selected articles here.

For the 32nd International Conference of Alzheimer's Disease International (ADI), BioMed Central has exhibited in this year’s conference and pulled together a selection of some of our top articles from Alzheimer's Research & Therapy, broadly based on the themes to be presented at the conference and showcasing some of the latest developments in Alzheimer’s research.

BioMed Central in the news
New human rights laws to prepare for advances in neurotechnology that put the ‘freedom of the mind’ at risk have been proposed in Life Sciences, Society and Policy.

The research was widely reported by the international media with the majority of hits in the US and Turkey. In the UK, it was covered by outlets including The GuardianDaily MailThe Times and New Scientist. It was also reported by The Hindu in India and Die Welt in Germany.

When trying to pick the most flattering pictures for online profiles, it may be best to let a stranger do the choosing, a study published in Cognitive Research: Principles and Implications suggests.

The research captured the imagination of national and international media. In the UK, it was reported by outlets including The Daily TelegraphThe Daily Mail, and The Independent. It was widely syndicated in the US and covered by outlets including TIME MagazineUSA Today, and LiveScience. It was also syndicated widely in India and covered by outlets including Times of India, as well as by O Globo in Brazil, Spektrum der Wissenschaft in Germany, Independent.ie in Ireland, and IFL Science in Canada.

Experiments carried out in mice have revealed that a compound commonly found in extra-virgin olive oil can reverse some of the negative effects of a high-fat diet. The results are published in Lipids in Health and Disease.

The research was covered by The Scotsman and The Express in the UK, as well as Times of India. It also generated significant global coverage with the majority of media stories in Russia and India.

A ‘Historic Book Odour Wheel’ which has been developed to document and archive the aroma associated with old books, was presented in a study in Heritage Science.

The research was reported by national and international media. In the UK, it was covered by outlets including The Daily TelegraphBBC NewsThe GuardianThe Daily MailThe TimesITV.com and Motherboard. It was widely syndicated in the US and covered by outlets including Smithsonian.com. It was also reported by O Globo in Brazil, La Repubblica in Italy, and CTV News in Canada.

A study of nearly 280,000 women in the United States, published in Breast Cancer Research, found that living in areas with a high level of fine particles from air pollution may increase a woman’s chance of having dense breasts – a well-established risk factor for breast cancer.

The article generated significant global coverage with the majority of media stories in the United States. The research was covered by The Daily MailThe SunThe Times and the Press Association in the UK, and by The Australian and Sky News in Australia. Coverage by Health Day News led to wide syndication of the story to local news outlets across the US.

The most popular blog across the whole of the BMC blog network – our quiz in honour of DNA Day on 25th April – was published in ‘On Biology’, receiving 1,460 views.

Test your own knowledge of DNA here. For some help, find out more about the latest advances in our special DNA Day 2017 article collection.

BioMed Central on the Road
San Diego, USA, 6/9/2017

Seoul, South Korea, 6/22/2017

Boston, United States, 6/14/2017

Best wishes,

The BMC Update Team

For further information or enquiries please contact Customer Services at:info@biomedcentral.com.
BioMed Central Ltd 
236 Gray's Inn Road, London, WC1X 8HB, 

United Kingdom.

No hay comentarios:

Publicar un comentario